Key result
Cell-based therapies for cardiac repair may enhance cardiac function post-myocardial infarction by secreting paracrine factors that polarize pro-reparative T cell subsets.
Why the study?
Cell-based therapies enhance cardiac function after myocardial infarction, but the mechanisms and specifically the polarization of different T cell subsets after stem cell transplantation remain poorly understood.
This review highlights the mechanisms by which stem cell therapies modulate adaptive immune responses, specifically T cell polarization, to promote cardiac repair after myocardial infarction.
T cell modulation may aid post-MI repair; extends immune insights while leaving polarization mechanisms unresolved.
Ischemic injury to the heart causes cardiomyocyte and supportive tissue death that result in adverse remodeling and formation of scar tissue at the site of injury. The dying cardiac tissue secretes a variety of cytokines and chemokines that trigger an inflammatory response and elicit the recruitment and activation of cardiac immune cells to the injury site. Cell-based therapies for cardiac repair have enhanced cardiac function in the injured myocardium, but the mechanisms remain debatable. In this review, we will focus on the interactions between the adoptively transferred stem cells and the post-ischemic environment, including the active components of the immune/inflammatory response that can mediate cardiac outcome after ischemic injury. In particular, we highlight how the adaptive immune cell response can mediate tissue repair following cardiac injury. Several cell-based studies have reported an increase in pro-reparative T cell subsets after stem cell transplantation. Paracrine factors secreted by stem cells polarize T cell subsets partially by exogenous ubiquitination, which can induce differentiation of T cell subset to promote tissue repair after myocardial infarction (MI). However, the mechanism behind the polarization of different subset after stem cell transplantation remains poorly understood. In this review, we will summarize the current status of immune cells within the heart post-MI with an emphasis on T cell mediated reparative response after ischemic injury.
No takes yet. Share an insight, caveat, or question.
Kino et al. (2020) conducted a review in Myocardial Infarction. Cell-based therapies was evaluated. Cell-based therapies for cardiac repair may enhance cardiac function post-myocardial infarction by secreting paracrine factors that polarize pro-reparative T cell subsets.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: